The secondary objective was to identify how PSA levels were affected by other factors such as age at prostate cancer diagnosis, age at starting GAHT, how long received GAHT prior to diagnosis, type of GAHT regimen, and orchidectomy status. This evidence concerns the gene KLK3 and Familial prostate cancer.